このエピソードについて

英語
アメリカ合衆国

文字起こし 🔗

過去のエピソードを検索

B2B Effectivenessの以前のエピソードを検索します。

このポッドキャストの他のエピソード

Imagine a medical test that tells a patient they have cancer, but is wrong 19 times out of 20. No regulator would ever allow it near a hospital. Yet for roughly twenty years, that's been about the accuracy of the average B2B lead scoring system — long-running Gartner benchmark data puts MQL accepta…
Run the numbers on almost any B2B company's accounts, and a strange pattern shows up: the top 10% of your top 20% highest-revenue accounts tend to be your absolute lowest-profit accounts. They cost a fortune to land, a fortune to service, and know they can make unreasonable demands you can't refuse…
Take every account your company has ever closed-won, upload the list to an ad platform, and ask it to find more companies that look just like them. Here's the uncomfortable part: every one of those accounts almost certainly has vowels in its name too. That's the opening argument in this solo episod…
The 95-5 rule is one of B2B marketing's favourite soundbites: at any given moment, only 5% of your market is in-market to buy. It gets cited as settled fact in board meetings and budget arguments — and in most fast-growing B2B tech categories, it's wrong by a factor of five or more. In Episode 4, …
A B2B SaaS company once found that accounts on Amazon FBA generated ten to twenty times more lifetime value than accounts on Etsy or eBay — even though the sales effort to close either one was statistically identical. If your lead qualification can't tell the difference between those two prospects,…
免責: このページに埋め込まれているポッドキャストとアートワークは The Insight Collective からのものであり、その所有者の所有物であり、Listen Notes, Inc. と提携または承認されていません。